Real patients.
Reliable feasibility. Faster start.
Talk to our Experts
Discover Insights
Why This Matters
The patients exist.
They're just not visible.
Most eligible study patients are treated in outpatient settings, in practices outside your site network. Classical feasibility methods don't capture this population. The result: underestimated recruitment potential, overly optimistic timelines, and high screen failure rates. MPIRIQ changes that. AI-supported data extraction directly from routine care, structured, pseudonymised, and aligned to your protocol criteria.
Two application areas
Pre-Feasibility
Reliable patient numbers from real care data before sites are selected. No estimates, no extrapolations from historical records.
Patient Matching
Automated screening against inclusion and exclusion criteria directly in the patient population of participating practices, for faster identification and fewer screen failures.
What We Do
Precision Matching
New Patient Access
Validated Data Quality
WHY MPIRIQ
Transparent Consent
Ethical collaboration. Real Impact.
GDPR compliant by design
FAQ
How reliable are MPIRIQ's patient numbers for feasibility?
MPIRIQ pulls directly from routine outpatient documentation — not site estimates or historical records. You get real patient numbers from the actual care population, structured against your protocol criteria, before a single site is selected.
How does MPIRIQ reduce screen failure rates?
Automated screening against your inclusion and exclusion criteria happens directly in the patient population of participating practices. Only patients who match your protocol profile are flagged — reducing the gap between screened and enrolled patients significantly.
How early in the trial planning process can MPIRIQ be involved?
From day one. MPIRIQ is designed for pre-feasibility - giving clinical operations teams a reliable patient population assessment before site selection, country allocation, or timeline commitments are made.




